S Y Tse
Chief Executive Officer bij SINO BIOPHARMACEUTICAL LIMITED
Vermogen: 1 565 M $ op 31-03-2024
Profiel
S Y Tse zit in de raad van bestuur van Sino Biopharmaceutical Ltd. S Y Tse behaalde een bachelor aan The Wharton School van de Universiteit van Pennsylvania en een master aan het Schwarzman College.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
19-04-2024 | 4 055 000 000 ( 21.57% ) | 1 565 M $ | 31-03-2024 |
Actieve functies van S Y Tse
Bedrijven | Functie | Begin |
---|---|---|
SINO BIOPHARMACEUTICAL LIMITED | Chief Executive Officer | 28-07-2022 |
Chengdu Quanyuantang Pharmacy Chain Joint Stock Co., Ltd.
Chengdu Quanyuantang Pharmacy Chain Joint Stock Co., Ltd. Pharmaceuticals: MajorHealth Technology Chengdu Quanyuantang Pharmacy Chain Joint Stock Co., Ltd. is an omni-channel smart retail pharmacy. It operates both offline and online retail pharmacies. It sells and delivers pharmaceutical products through its O2O and B2C platforms. It is also involved in the wholesale of pharmaceutical products to other industry customers. The company was founded by Can Li and Zhou Hua Chen on September 12, 2012 and is headquartered in Chengdu, China. | Director/Board Member | 10-11-2020 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The private company was founded in 1969, and the CEO is Kang Xin Yu. | Chairman | 30-07-2020 |
Eerdere bekende functies van S Y Tse
Bedrijven | Functie | Einde |
---|---|---|
Liepin North America, Inc. | Chief Executive Officer | - |
Opleiding van S Y Tse
The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Schwarzman College | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
SINO BIOPHARMACEUTICAL LIMITED | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The private company was founded in 1969, and the CEO is Kang Xin Yu. | Health Technology |
Chengdu Quanyuantang Pharmacy Chain Joint Stock Co., Ltd.
Chengdu Quanyuantang Pharmacy Chain Joint Stock Co., Ltd. Pharmaceuticals: MajorHealth Technology Chengdu Quanyuantang Pharmacy Chain Joint Stock Co., Ltd. is an omni-channel smart retail pharmacy. It operates both offline and online retail pharmacies. It sells and delivers pharmaceutical products through its O2O and B2C platforms. It is also involved in the wholesale of pharmaceutical products to other industry customers. The company was founded by Can Li and Zhou Hua Chen on September 12, 2012 and is headquartered in Chengdu, China. | Health Technology |
Liepin North America, Inc. |